Document Detail


Effects of 5-fluorouracil derivative UFT on thymidylate synthetase and thymidine kinase in rat colorectal tumors.
MedLine Citation:
PMID:  10226549     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Thymidylate synthetase and thymidine kinase are key enzymes involved in de novo and salvage pathways for pyrimidine nucleotide synthesis, respectively. MATERIALS AND METHODS: Weekly injections of 1,2-dimethyl-hydrazine induced high incidence of colorectal adenocarcinomas in rats. RESULTS: An increased activity of thymidylate synthetase was found in the poorly differentiated adenocarcinomas of the chemically induced rat colorectal tumors. Six-week oral administration of 1-(2-tetrahydrofuryl)-5-fluorouracil in combination with uracil (UFT) reduced the total number of colorectal tumors, with the reduction of thymidylate synthetase activity in the poorly-differentiated type, though the mRNA expression of thymidylate synthetase and thymidine kinase differed little between the groups with or without UFT treatment. CONCLUSIONS: These results indicate that the long-term oral administration using UFT suppresses colorectal carcinogenesis and the growth of the poorly-differentiated type tumors.
Authors:
S Sakamoto; Y Kawachi; T Iwama; K Kuwa; T Suzuki; T Mitamura; H Kudo; S Sassa; S Yoshimura; T Maemura; T Nakayama; M Ohsawa; Y Hara
Related Documents :
20577779 - Convection enhanced delivery of carboplatin in combination with radiotherapy for the tr...
8841509 - Activity and characterization of sialyltransferase from serum of normal rats, of rats b...
17447859 - Effect of prolonged psychoemotional stress and melatonin on experimental mammary carcin...
6707699 - Effect of frequency of plasma adsorption over protein a-containing staphylococcus aureu...
23305239 - Anti-angiogenic and anti-tumor effects of tak-593, a potent and selective inhibitor of ...
7203399 - Pheochromocytoma: an animal model.
7540949 - Mouse skin tumor progression results in differential expression of retinoic acid and re...
18350919 - Benign cardiac tumors of the pluripotent mesenchyme.
19509229 - Roc1/rbx1 e3 ubiquitin ligase silencing suppresses tumor cell growth via sequential ind...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Anticancer research     Volume:  19     ISSN:  0250-7005     ISO Abbreviation:  Anticancer Res.     Publication Date:    1999 Jan-Feb
Date Detail:
Created Date:  1999-05-20     Completed Date:  1999-05-20     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  GREECE    
Other Details:
Languages:  eng     Pagination:  245-50     Citation Subset:  IM    
Affiliation:
Department of Surgery, School of Medicine, Tokyo Medical and Dental University, Japan. motoend@mri.tmd.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antineoplastic Agents / therapeutic use*
Colorectal Neoplasms / drug therapy*,  enzymology,  pathology
Drug Combinations
Male
RNA, Messenger / analysis
Rats
Tegafur / pharmacology*
Thymidine Kinase / genetics,  metabolism*
Thymidylate Synthase / genetics,  metabolism*
Uracil / pharmacology*
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Drug Combinations; 0/RNA, Messenger; 0/UFT(R) drug; 17902-23-7/Tegafur; 66-22-8/Uracil; EC 2.1.1.45/Thymidylate Synthase; EC 2.7.1.21/Thymidine Kinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Isolation and biological activities of an antineoplastic protein-polysaccharide complex (PS4A) obtai...
Next Document:  Reversal of methotrexate resistance in human squamous carcinoma cells by SQM1-liposome.